• Amuron B, Namara G, Birungi J et al. (2009) Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9, 290.
  • Bassett IV, Wang B, Chetty S et al. (2009) Loss to care and death before antiretroviral therapy in Durban South Africa. Journal of Acquired Immune Deficiency Syndromes 51, 135139.
  • Egger M (2007) Outcomes of antiretroviral treatment in resource limited and industrialized countries (Abstract 62). 14th Conference on Retroviruses and Opportunistic Infections , Los Angeles.
  • Fairall LR, Bachmann MO, Louwagie GM et al. (2008) Effectiveness of antiretroviral treatment in a South African program: a cohort study. Archives of Internal Medicine 168, 8693.
  • Horne R, Cooper V, Gellaitry G, Date H & Fisher M (2007) Patients’ perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. Journal of Acquired Immune Deficiency Syndrome 45, 334341.
  • Jones P (2005) On a never-ending waiting list: toward equitable access to anti-retroviral treatment? Experiences from Zambia. Health and Human Rights 8, 76102.
  • Kigozi IM, Dobkin LM, Martin JN et al. (2010) Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes 52, 280289. 10.1097/QAI0b013e3181ab6eab .
  • Kinsler J, Wong M, Sayles J, Davis C & Cunningham W (2007) The effect of perceived stigma from a health care provider on access to care among a low-income HIV-positive population. Aids Patient Care and STDS 21, 584592.
  • Larson BA, Brennan A, Mcnamara L et al. (2009) A Lost Opportunity: Most VCT Patients Who Test Positive for HIV in a Large South African Clinic do not Initiate HIV Care. Boston, University, Boston.
  • Lawn S, D Myer L, Orrell C, Bekker LG & Wood R (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19, 21412148.
  • Lawn SD, Myer L, Harling G, Orrell C, Bekker LG & Wood R (2006) Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clinical Infectious Diseases 43, 770776.
  • Makombe SD, Jahn A, Tweya H et al. (2007) A national survey of teachers on antiretroviral therapy in Malawi: access retention in therapy and survival. PLoS ONE 2, e620.
  • Mcnutt LA, Wu C, Xue X & Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. American Journal of Epidemiology 157, 940943.
  • Mshana GH, Wamoyi J, Busza J et al. (2006) Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS 20, 649657.
  • Muula A, Ngulube T, Siziya S et al. (2007) Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 7, 63.
  • Rosen S, Long L & Sanne I (2008) The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Tropical Medicine & International Health 13, 111.
  • South African National Department of Health (2007) HIV and AIDS and STI Strategic Plan for South Africa 2007–2011. MoH, Pretoria.
  • Wilson D & Blower S (2007) How far will we need to go to reach HIV-infected people in rural South Africa? BMC Medicine 5, 16.
  • Zou G (2004) A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology 159, 702706.